September 2014

Presented by:

Larry Gershman

Gerald Kieft

GelStat Corporation (symbol “GSAC”) is engaged in the development, manufacturing, marketing and branding of innovative over-the-counter (OTC) consumer healthcare

products addressing very large markets.

Disclaimer

THIS PRESENTATION IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE ANOFFER OR SOLICITATION. FURTHERMORE, ALL INFORMATION CONTAINED IN THISPRESENTATION CONSTITUTES CONFIDENTIAL INFORMATION OF THE COMPANY. ANYREPRODUCTION OR DISTRIBUTION OF THIS PRESENTATION, IN WHOLE OR IN PART, OR THEDIVULGING OF ANY OF ITS CONTENTS WITHOUT THE PRIOR WRITTEN CONSENT OF THECOMPANY IS STRICTLY PROHIBITED

THIS REPORT MAY CONTAIN FORWARD-LOOKING STATEMENTS, PARTICULARLY AS RELATED TOPRO FORMA FINANCIAL STATEMENTS, EARNINGS ESTIMATES AND BUSINESS EXPECTATIONS,WITHIN THE MEANING OF SECTION 27A OF THE SECURITIES ACT OF 1933 AND SECTIONS 21E OFTHE SECURITIES EXCHANGE ACT OF 1934, AND ARE SUBJECT TO THE SAFE HARBOR CREATED BYTHESE SECTIONS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECTTO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS,ASSUMPTIONS, FUTURE EVENTS, OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACTAND MAY BE "FORWARD LOOKING STATEMENTS." FORWARD LOOKING STATEMENTS ARE BASEDON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADETHAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUALRESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTED HEREIN.

Overview

GelStat is a vertically-integrated healthcare organization with development, manufacturing,marketing, and branding capabilities. As a result of the Mastix Medica acquisition in July 2014,GelStat now offers a proprietary process to manufacture gum and lozenges and can also infuseCBDs into these products.

Investment Considerations

A full portfolio of fully developed products

Fully integrated organization with development, manufacturing, marketing and branding capabilities

Significant intellectual property -- a patent on GelStat Migraine and patents pending on manufacturing processes for gums and lozenges and infusion technologies.

Unlimited potential with branding/distribution strategy

Positive clinical studies on GelStat Migraine, additional studies ongoing

GelStat Migraine is supported by leading consumer advocacy groups

Positive feedback and testimonials from customers

Investor friendly business model and management team with significant equity ownership

Multiple fully developed website/e-commerce platforms

Products address very large markets with unique formulations

Leadership – Officers and Advisors

Collectively, the officers and directors own over 50% of the company and arecurrently receiving minimal cash compensation.

Larry Gershman has been one of the most successful people in the world of advertising,integrated marketing, promotions, direct response and digital media. He has won thecoveted Promotion of the Year Award an unprecedented 6 times and was Promotion Man ofthe Year twice. His long and varied client list includes: Revlon, Gillette, Ford, Mazda,Citigroup, Kraft, Pepsi, RC Cola, Burger King and McDonald's to name but a few.

Larry's management skills have been proven repeatedly during his career having owned, builtor managed some of the most successful marketing companies in the World, includingOgilvy & Mather, Integrated Communications Group, Marden Kane, The Howard MarlboroGroup, Integrated Marketing & Promotional Solutions ("IMPS") among others.

Larry GershmanChairman & CEO

Gerald N. Kieft, Chief Financial Officer and Director

Mr. Kieft was the interim CEO for GelStat Corporation from June of 2008 until June of 2013.Mr. Kieft began his career as an analyst for the Loan Source in 1991, providing debt-fundingsources for small businesses through Small Business Association (SBA) loans. Subsequently,Mr. Kieft has founded, built and managed a number of successful companies as well as workedas a buy-side analyst for a hedge fund, a sell-side analyst for a boutique brokerage firm and as aconsultant to high net worth individuals and emerging growth companies at a number offinancial institutions including Prudential Securities, Legg Mason Wood Walker and RaymondJames & Associates. Throughout his career in the finance industry, Mr. Kieft has helpednumerous emerging growth companies obtain financing and investors. Mr. Kieft is a graduateof Eastern Illinois University, where he earned a Bachelor of Science in Business degree,majoring in Finance, as well as a Bachelor of Arts degree, majoring in Economics.

Leadership – Officers

The founder of Mastix Medica, Mr. Estey has led companies through successful turnaround andstart-up situations. In these situations, Mr. Estey had CFO and operational responsibilities at ANIPharmaceuticals, Xanodyne Pharmaceuticals, Alpharma’s U.S. Generic Pharmaceutical Divisionand Florida Tile Industries. Earlier in his career, Mr. Estey held a variety of increasinglyresponsible financial and operational positions in life science and consumer products companiesthat includes Pfizer, Praxis Biologics (now Wyeth), Everest Healthcare (now Fresenius), LeverBros. and Pennwalt (now UCB).

Mr. Estey holds a BA degree in Economics from Colgate University and an MBA in OperationsResearch from the Rochester Institute of Technology. He is also a Certified ManagementAccountant (CMA).

Bob Estey, Chief Operating Officer

Leadership – Advisors/Consultants

Roger Cady, M.D, Chief Medical Advisor

Dr. Cady is the founder of Headache Care Center, Clinvest, and Primary Care Education. He is a graduate of theMayo Medical School, and is Board Certified by the American Board of Family Practice. His board certificationin Headache Medicine was awarded by the United Council for Neurologic Subspecialties, and he holds aCertificate of Added Qualification through the National Board of Certification in Headache Management. He isa member of multiple medical associations, including the American Medical Association, the NationalHeadache Foundation, the American Headache Society, the American Academy of Pain Management, and theAmerican Academy of Family Physicians. Dr. Cady is best known in the medical community for his pivotalcontributions in the field of headache and migraine management. He was the co-recipient of the prestigiousWolff Award in 2000 from the American Headache Society for his research entitled "The Spectrum ofHeadache". He is well-published and has presented countless lectures and seminars around the world onheadache, migraine, and other chronic disorders, and continues to be the principal investigator in numerousmulti-center research studies. Dr. Cady currently serves on 12 Advisory Boards and is a member of the Board ofDirectors for the National Headache Foundation.

Tim Sweeney, Consultant – Branding and Marketing

Tim Sweeney is a senior management executive with over 25 years’ experience in marketing and sales. He startedhis career in advertising with Best Foods International’s Hellmann’s Mayonnaise and Skippy Peanut Butterbrands. Over the last 15years, he has concentrated on the Direct Response (DR) advertising of naturalsupplements as well as health and beauty aids working as in-house marketing consultant for the clients of VitaQuest International, the largest private label natural supplemental manufacturer in the U.S. This vastexperience as enabled him to steward products from basic concept to national retail expansion of directresponse developed brands such as H57 Hoodia, George Foreman’s LifeShake, and the Quick Trim Diet Planwith the Kardashian sisters.

Product Life Cycle

Lead by Dr. Roger Cady, who is best known in the medical community for his pivotal contributions in the

field of headache and migraine management. GelStat is dedicated

to developing natural products that are proven by science.

Through its wholly owned subsidiary Mastix Medica, LLC,

GelStat contract manufactures or private labels tableted chewing

gum, chewable tablets, lozenges, mints and candy for a wide variety of

customers. Most importantly, Mastix Medica is one of very few

companies in the world that has the ability to make functional chewing

gum products.

Following a rigorous research & development process, GelStat’shighly accomplished marketing

team goes to work bringing its new products to market.

Development Manufacturing Marketing/Branding

Initial Product Portfolio

• GelStat Migraine - Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, expects that the market for migraine therapies to increase from $3.3 billion in 2011 to $5.8 billion in 2021 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

• Chews 2 Lose – According to Marketdata Enterprises, Inc. , a leading independent market research publisher of “off-the-shelf” studies about service industries since 1979, an estimated 75 million dieters spent $2.7 billion in 2010 on diet pills and meal replacements.

• All Natural Speed – According an article published by Companies and Markets.com, the US energy drinks market is estimated to have increased by 60% over the past four years, hitting an estimated value of $12.5 billion in 2012. The industry is expected to continue this growth path, by rising to a valuation of $21.5 billion by 2017.

• GelStat Sleep - The total over-the-counter market for sleep aids alone reached $604 million in 2008, an increase of 9 percent over 2007, according to Packaged Facts, a division of Rockville, Md.-based Market Research Group.

Products – GelStat Migrainewww.TryGelStatMigraine.com

GelStat® Migraine Benefits of Product

Used as abortive product with fast onset of action

No reported side effects

Cost effective migraine relief

Available OTC, without a prescription

Pre-measured, single-dose dispensers are convenient, safe and effective

Unique sub-lingual administered product

Prevents risk of rebound headaches

Clinically validated effectiveness

3rd party validation of effectiveness

Vast amount of testimonials

Patented product

Patent # 7,192,614 on GelStat Migraine (compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms).

www.TeriRobert.com

www.migraines.org

Products – Chews 2 Lose

Chews 2 Lose

Innovative Appetite Suppressant Gum

Designed to work with ALL diet plans

#1 reason diets fail is cheating

Easy to use, just simply chew gum

75 Million American Dieters Annually

Custom formulation

Manufactured through wholly owned subsidiary significantly improves margins

NEED

IMAGE

Products – All Natural Speed

All Natural Speed

All Natural Energy Product in Capsule Form

Enormous Market Size - 5-Hour Energy alone reported over $1 billion in retail sales 2012

Enormity of category opens opportunity to address specific quick fix energy user groups

Edgy Product Targeting College Students Studying for Exams and Gamers

Highly Specialized Irreverent Advertising Campaign

Available OTC without a Prescription

Custom formulation buying direct from manufacturer delivers significant margins

Expected to be Available in the 3rd Quarter of 2014

Products – GelStat Sleep

GelStat® Sleep

Reduced Time to Fall Asleep

Increased Quality of Sleep

No Drowsiness or “Hangover Feeling” the Following Day

Available OTC without a Prescription

Numerous Positive Testimonials

Significant Margins

Large Market Size

Potential usage for professionals with irregular sleep patterns (pilots, nurses, machine operators, military personnel.)

Expected to be Relaunched in the 4th Quarter of 2014

CBDs – A growing industry and opportunity

The Hemp and Marijuana plants contain THC and CBD compounds that have important properties and benefits.

THCs (tetrahydracannabinoids) generate a pyschoactive high.

CBDs (cannabinoids) provide healing through reducing inflammations and is an anti-oxidant as well as having other medicinal properties.

GelStat is in the process of developing products for enhanced sleep, migraine, arthritic relief by including CBDs within its formulations. It is anticipated that these products will be ready in mid 2015.

Manufacturing Capabilities

Through our Mastix Medica subsidiary, GelStat is now capable of manufacturing:

CBD oil infused Gums & Lozenges

Tableted Chewing Gum

Chewable Tablets and Lozenges

Supplements, Herbals & Botanicals

Kosher certified and allergen-free

Specialty Candies

Most importantly it is the only company capable of manufacturing powdered gum in the world.

See GelStat webpage for manufacturing details -http://www.gelstat.com/manufacturing/overview

Marketing - Strategy

The marketing approach known as Hybrid Direct Response Retail Support (HDRRS) campaign is the best approach for GelStat’s brands for the retail marketplace. The HDRRS principle is simple: combine a direct response sales and branding campaign with strategic rollout into select retail locations.

Why follow this approach? Because there have not been any brands successful at the retail level that have first failed in Direct Response (DR); however, there have been several hugely successful Health and Beauty Aid (HBA) retail brands that were cultivated from Direct Response campaigns.

Therefore we intend to use this tried and true strategy as our primary marketing strategy for current and future products by beginning with a direct-to-consumer campaign and then move into select retail markets over time.

Marketing– GelStat Migraine

www.TryGelstatMigraine.com

Capital Structure 9-15-14

Common Stock:

500,000,000 Shares authorized375,000,000 Shares issued and outstanding55,000,000 Shares in market at CEDE

Preferred Stock: None Issued

Summary

A world class management team

4 initial products

A suite of products in development related to CBDs

Mastix Medica offers a unique technology sought by industry

Contract manufacturing with licensing capabilities

Significant patent protection and applications

Capital sought for marketing/inventory

3545 SW Corporate Parkway

Palm City, FL 34990

(772) 283-0020 (Tel)

(772) 219-3579 (Fax)

info@gelstat.com

Websites:

www.GelStat.com

www.GelStatMigraine.com